|
1
|
Marcu LG and Yeoh E: A review of risk
factors and genetic alterations in head and neck carcinogenesis and
implications for current and future approaches to treatment. J
Cancer Res Clin Oncol. 135:1303–1314. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bodnar M, Szylberg Ł, Kaźmierczak W and
Marszalek A: Immunohistochemical expression of p27(kip1) in
metastatic laryngeal squamous cell carcinoma. Adv Med Sci.
59:206–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li M, Tian L, Ren H, Chen X, Wang Y, Ge J,
Wu S, Sun Y, Liu M and Xiao H: MicroRNA-101 is a potential
prognostic indicator of laryngeal squamous cell carcinoma and
modulates CDK8. J Transl Med. 13:2712015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alcohol drinking. Epidemiological studies
of cancer in humans. IARC Monogr Eval Carcinog Risks Hum.
44:153–250. 1988.PubMed/NCBI
|
|
6
|
Edefonti V, Bravi F, Garavello W, La
Vecchia C, Parpinel M, Franceschi S, Dal Maso L, Bosetti C,
Boffetta P, Ferraroni M and Decarli A: Nutrient-based dietary
patterns and laryngeal cancer: Evidence from an exploratory factor
analysis. Cancer Epidemiol Biomarkers Prev. 19:18–27. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yungang W, Xiaoyu L, Pang T, Wenming L and
Pan X: miR-370 targeted FoxM1 functions as a tumor suppressor in
laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother.
68:149–154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boyle P and Ferlay J: Cancer incidence and
mortality in Europe, 2004. Ann Oncol. 16:481–488. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ramroth H, Schoeps A, Rudolph E, Dyckhoff
G, Plinkert P, Lippert B, Feist K, Delank KW, Scheuermann K, Baier
G, et al: Factors predicting survival after diagnosis of laryngeal
cancer. Oral Oncol. 47:1154–1158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 9:8522017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gibcus JH, Tan LP, Harms G, Schakel RN, de
Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ and van den
Berg A: Hodgkin lymphoma cell lines are characterized by a specific
miRNA expression profile. Neoplasia. 11:167–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leaman D, Chen PY, Fak J, Yalcin A, Pearce
M, Unnerstall U, Marks DS, Sander C, Tuschl T and Gaul U:
Antisense-mediated depletion reveals essential and specific
functions of microRNAs in Drosophila development. Cell.
121:1097–1108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: Bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fiore R, Siegel G and Schratt G: MicroRNA
function in neuronal development, plasticity and disease. Biochim
Biophys Acta. 1779:471–478. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
O'Connell RM, Taganov KD, Boldin MP, Cheng
G and Baltimore D: MicroRNA-155 is induced during the macrophage
inflammatory response. Proc Natl Acad Sci USA. 104:1604–1609. 2007;
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calin GA and Croce CM: MicroRNA-cancer
connection: The beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu JY, Lu JB and Xu Y: MicroRNA-153
inhibits the proliferation and invasion of human laryngeal squamous
cell carcinoma by targeting KLF5. Exp Ther Med. 11:2503–2508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Geng J, Liu Y, Jin Y, Tai J, Zhang J, Xiao
X, Chu P, Yu Y, Wang SC, Lu J, et al: MicroRNA-365a-3p promotes
tumor growth and metastasis in laryngeal squamous cell carcinoma.
Oncol Rep. 35:2017–2026. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu H, Hu YW, Zhao JY, Hu XM, Li SF, Wang
YC, Gao JJ, Sha YH, Kang CM, Lin L, et al: MicroRNA-195-5p acts as
an anti-oncogene by targeting PHF19 in hepatocellular carcinoma.
Oncol Rep. 34:175–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng C, Li J, Wang Q, Liu W, Zhou J, Liu
R, Zeng Q, Peng X, Huang C, Cao P and Cao K: MicroRNA-195 functions
as a tumor suppressor by inhibiting CBX4 in hepatocellular
carcinoma. Oncol Rep. 33:1115–1122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and
Zhuang SM: MicroRNA-195 suppresses tumorigenicity and regulates
G1/S transition of human hepatocellular carcinoma cells.
Hepatology. 50:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Wang J, Ma H, Zhang J and Zhou X:
Downregulation of miR-195 correlates with lymph node metastasis and
poor prognosis in colorectal cancer. Med Oncol. 29:919–927. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song CG, Wu XY, Wang C, Fu FM and Shao ZM:
Correlation of miR-195 with invasiveness and prognosis of breast
cancer. Zhonghua Wai Ke Za Zhi. 50:353–356. 2012.(In Chinese).
PubMed/NCBI
|
|
28
|
Fei X, Qi M, Wu B, Song Y, Wang Y and Li
T: MicroRNA-195-5p suppresses glucose uptake and proliferation of
human bladder cancer T24 cells by regulating GLUT3 expression. FEBS
Lett. 586:392–397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang QQ, Xu H, Huang MB, Ma LM, Huang QJ,
Yao Q, Zhou H and Qu LH: MicroRNA-195 plays a tumor-suppressor role
in human glioblastoma cells by targeting signaling pathways
involved in cellular proliferation and invasion. Neuro Oncol.
14:278–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deng H, Guo Y, Song H, Xiao B, Sun W, Liu
Z, Yu X, Xia T, Cui L and Guo J: MicroRNA-195 and microRNA-378
mediate tumor growth suppression by epigenetical regulation in
gastric cancer. Gene. 518:351–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hui W, Yuntao L, Lun L, WenSheng L,
ChaoFeng L, HaiYong H and Yueyang B: MicroRNA-195 inhibits the
proliferation of human glioma cells by directly targeting cyclin D1
and cyclin E1. PLoS One. 8:e549322013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jia LF, Wei SB, Gong K, Gan YH and Yu GY:
Prognostic implications of micoRNA miR-195 expression in human
tongue squamous cell carcinoma. PLoS One. 8:e566342013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yongchun Z, Linwei T, Xicai W, Lianhua Y,
Guangqiang Z, Ming Y, Guanjian L, Yujie L and Yunchao H:
MicroRNA-195 inhibits non-small cell lung cancer cell
proliferation, migration and invasion by targeting MYB. Cancer
Lett. 347:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang Y, Li M, Chang S, Wang L, Song T, Gao
L, Hu L, Li Z, Liu L, Yao J and Huang C: MicroRNA-195 acts as a
tumor suppressor by directly targeting Wnt3a in HepG2
hepatocellular carcinoma cells. Mol Med Rep. 10:2643–2648. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang X, Yu J, Yin J, Xiang Q, Tang H and
Lei X: MiR-195 regulates cell apoptosis of human hepatocellular
carcinoma cells by targeting LATS2. Pharmazie. 67:645–651.
2012.PubMed/NCBI
|
|
36
|
Zhou Q, Han LR, Zhou YX and Li Y: MiR-195
suppresses cervical cancer migration and invasion through targeting
Smad3. Int J Gynecol Cancer. 26:817–824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu L, Chen L, Xu Y, Li R and Du X:
microRNA-195 promotes apoptosis and suppresses tumorigenicity of
human colorectal cancer cells. Biochem Biophys Res Commun.
400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang L, Qian L, Li X and Yan J:
MicroRNA-195 inhibits colorectal cancer cell proliferation,
colony-formation and invasion through targeting CARMA3. Mol Med
Rep. 10:473–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Qu J, Zhao L, Zhang P, Wang J, Xu N, Mi W,
Jiang X, Zhang C and Qu J: MicroRNA-195 chemosensitizes colon
cancer cells to the chemotherapeutic drug doxorubicin by targeting
the first binding site of BCL2L2 mRNA. J Cell Physiol. 230:535–545.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang X, Tao T, Liu C, Guan H, Huang Y, Xu
B and Chen M: Downregulation of miR-195 promotes prostate cancer
progression by targeting HMGA1. Oncol Rep. 36:376–382. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang
L, Lu K, Tao T, Zhang X and Huang Y: miR-195 inhibits EMT by
targeting FGF2 in prostate cancer cells. PLoS One. 10:e01440732015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo J, Wang M and Liu X: MicroRNA-195
suppresses tumor cell proliferation and metastasis by directly
targeting BCOX1 in prostate carcinoma. J Exp Clin Cancer Res.
34:912015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li D, Zhao Y, Liu C, Chen X, Qi Y, Jiang
Y, Zou C, Zhang X, Liu S, Wang X, et al: Analysis of MiR-195 and
MiR-497 expression, regulation and role in breast cancer. Clin
Cancer Res. 17:1722–1730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang G, Wu D, Zhu J, Jiang O, Shi Q, Tian
J and Weng Y: Upregulation of miR-195 increases the sensitivity of
breast cancer cells to Adriamycin treatment through inhibition of
Raf-1. Oncol Rep. 30:877–889. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhu J, Ye Q, Chang L, Xiong W, He Q and Li
W: Upregulation of miR-195 enhances the radiosensitivity of breast
cancer cells through the inhibition of BCL-2. Int J Clin Exp Med.
8:9142–9148. 2015.PubMed/NCBI
|
|
46
|
Luo Q, Wei C, Li X, Li J, Chen L, Huang Y,
Song H, Li D and Fang L: MicroRNA-195-5p is a potential diagnostic
and therapeutic target for breast cancer. Oncol Rep. 31:1096–1102.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Singh R, Yadav V, Kumar S and Saini N:
MicroRNA-195 inhibits proliferation, invasion and metastasis in
breast cancer cells by targeting FASN HMGCR, ACACA and CYP27B1. Sci
Rep. 5:174542015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu B, Qu J, Xu F, Guo Y, Wang Y, Yu H and
Qian B: MiR-195 suppresses non-small cell lung cancer by targeting
CHEK1. Oncotarget. 6:9445–9456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang C, Zhang S, Zhang Z, He J, Xu Y and
Liu S: ROCK has a crucial role in regulating prostate tumor growth
through interaction with c-Myc. Oncogene. 33:5582–5591. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rossman KL, Der CJ and Sondek J: GEF means
go: Turning on RHO GTPases with guanine nucleotide-exchange
factors. Nat Rev Mol Cell Biol. 6:167–180. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Patel RA, Forinash KD, Pireddu R, Sun Y,
Sun N, Martin MP, Schönbrunn E, Lawrence NJ and Sebti SM: RKI-1447
is a potent inhibitor of the Rho-associated ROCK kinases with
anti-invasive and antitumor activities in breast cancer. Cancer
Res. 72:5025–5034. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lock FE, Ryan KR, Poulter NS, Parsons M
and Hotchin NA: Differential regulation of adhesion complex
turnover by ROCK1 and ROCK2. PLoS One. 7:e314232012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhang J, He X, Ma Y, Liu Y, Shi H, Guo W
and Liu L: Overexpression of ROCK1 and ROCK2 inhibits human
laryngeal squamous cell carcinoma. Int J Clin Exp Pathol.
8:244–251. 2015.PubMed/NCBI
|
